相关实验视频

Updated: Sep 10, 2025

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

在社区居住的老年人中与大脑粉样血管病变相关的皮质灰质蛋白:解剖研究

Shahram Oveisgharan^1,2, Lei Yu^1,2, Jingyun Yang^1,2

¹Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.

|August 22, 2025

概括

大脑粉样蛋白血管病 (CAA) 涉及大脑血管中的β-粉样蛋白 (Aβ) 积累. 这项研究确定了与CAA相关的两个分子通路,其中一个涉及SFRP1和APOE蛋白和截断的Aβ,为其机制提供了新的见解.

科学领域:

神经科学
蛋白质组学
神经病理学

背景情况:

大脑粉样蛋白血管病变 (CAA) 的特征是大脑血管中的β-粉样蛋白 (Aβ) 积累.
CAA是脑内出血和痴呆的重要危险因素.
导致CAA的精确分子机制在很大程度上是未知的.

研究的目的:

研究皮质蛋白与CAA之间的关系.
阐明CAA病变的分子基础.

主要方法:

在5个社区中对887名老年人的皮质组织进行蛋白质组分析.
使用质谱测量量蛋白质,包括总Aβ和Aβ38.
顺序逻辑回归模型评估了与CAA的蛋白质关联,控制了阿尔茨海默病的病理.

主要成果:

最初有80种蛋白质与CAA相关;在对阿尔茨海默病 (AD) 病理进行调整后,仍有12种蛋白质.
四种蛋白质 - - 分泌的模块化结合蛋白1 (SMOC1),分泌的状相关蛋白1 (SFRP1),APOE和APOE4 - - 独立地与CAA相关.
确定了两个分子通路:一个涉及Aβ38,SFRP1和APOE蛋白 (更大的效果大小),另一个涉及Aβ负荷,总Aβ蛋白,SMOC1和APOE4 (更小的效果大小).

结论:

这项研究表明有两种不同的分子途径导致CAA.
一个涉及SFRP1,APOE蛋白和C端截断的Aβ (在位置40之前) 的途径显示了与CAA的更强的关联.
结果来自观察性,截面研究,限制因果推理.

更多相关视频

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval

Published on: April 23, 2010

相关概念视频

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...